Aptose Biosciences Inc. (NASDAQ:APTO) Q2 2023 Earnings Call Transcript

Aptose Biosciences Inc. (NASDAQ:APTO) Q2 2023 Earnings Call Transcript August 10, 2023

Aptose Biosciences Inc. misses on earnings expectations. Reported EPS is $-2.27 EPS, expectations were $-2.09.

Operator: Good afternoon. My name is Zeda and I will be your conference operator today. I would like to welcome everyone to the Aptose Biosciences Conference Call for the Second Quarter Ended June 30, 2023. At this time, all participants are in listen-only mode. After the speakers’ remarks,...